[Psychopathometric methods for the testing of psychopharmaceuticals. Efficiency increase]

Area of Science:

• Psychopharmacology
• Psychometrics
• Clinical Trials

Context:

• Psychopharmacological drug testing relies heavily on psychopathometric procedures.
• Test efficiency and validity are crucial for clinical trial rentability.
• Patient-centered approaches necessitate robust and varied testing methods.

Purpose:

• To evaluate the impact of psychopathometric procedures on the rentability and validity of psychopharmacological drug trials.
• To explore the potential of time-series analysis for economizing clinical assessments.
• To investigate the information yield of combined objective and self-rating scales in depressive patients.

Summary:

• Shorter and simpler tests enhance both the rentability and validity of psychopharmacological examinations.
• Procedures that accommodate patient needs increase validity but decrease rentability due to demands for variation and robustness.
• Time-series investigations offer economizing potential for trials, particularly for reversible psychoses and cyclothymic depression.
• A study using the antidepressant Mefexamid with depressive patients indicated that individual tests provided 84% of the information obtained when used with a second scale.

Impact:

• Findings suggest that optimizing test design and methodology can significantly improve the efficiency and cost-effectiveness of drug development.
• The study highlights the trade-offs between test comprehensiveness and practical rentability in clinical settings.
• Results provide a basis for refining assessment strategies in psychopharmacological research, potentially accelerating the development of new treatments.